• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Guidelines for detection and management of dyslipidaemia. Scientific Committee of the National Heart Foundation of New Zealand.

作者信息

Mann J I, Crooke M, Fear H, Hay D R, Jackson R T, Neutze J M, White H D

出版信息

N Z Med J. 1993 Apr 14;106(953):133-41.

PMID:8474734
Abstract
摘要

相似文献

1
Guidelines for detection and management of dyslipidaemia. Scientific Committee of the National Heart Foundation of New Zealand.
N Z Med J. 1993 Apr 14;106(953):133-41.
2
New guidelines for blood cholesterol by the National Cholesterol Education Program (NCEP). National Cholesterol Education Program (NCEP).
Prog Cardiovasc Nurs. 1994 Winter;9(1):43-4.
3
Detection and treatment of mild/moderate hypercholesterolemia is clearly beneficial for the prevention of coronary disease: antagonist's opinion.轻度/中度高胆固醇血症的检测与治疗对冠心病预防显然有益：反对者观点。
Can J Cardiol. 1994 Jun;10(5):533-4.
4
Detection and treatment of elevated blood cholesterol. What have we learned?高胆固醇血症的检测与治疗。我们学到了什么？
Arch Intern Med. 1991 Jan;151(1):25-8.
5
Elevated blood cholesterol. A risk factor for coronary heart disease.血液胆固醇升高。冠心病的一个风险因素。
AAOHN J. 1990 May;38(5):211-5.
6
1996 National Heart Foundation clinical guidelines for the assessment and management of dyslipidaemia. Dyslipidaemia Advisory Group on behalf of the scientific committee of the National Heart Foundation of New Zealand.1996年新西兰心脏基金会血脂异常评估与管理临床指南。血脂异常咨询小组代表新西兰心脏基金会科学委员会制定。
N Z Med J. 1996 Jun 28;109(1024):224-31.
7
The heart of the matter. National guidelines urge more aggressive cholesterol treatment.问题的核心。国家指南敦促更积极地进行胆固醇治疗。
Adv Nurse Pract. 2002 Jan;10(1):42-7; quiz 48-9.
8
[Guidelines for management of patients with hypercholesterolemia].[高胆固醇血症患者管理指南]
Nihon Rinsho. 2001 Mar;59 Suppl 3:500-4.
9
New therapeutic options in the National Cholesterol Education Program Adult Treatment Panel III.美国国家胆固醇教育计划成人治疗组第三次报告中的新治疗选择。
Am J Manag Care. 2002 Sep;8(12 Suppl):S301-7.
10
American Academy of Pediatrics. Committee on Nutrition. Cholesterol in childhood.美国儿科学会。营养委员会。儿童期胆固醇
Pediatrics. 1998 Jan;101(1 Pt 1):141-7.

引用本文的文献

1
Cardiovascular risk assessment: a global perspective.心血管风险评估：全球视角。
Nat Rev Cardiol. 2015 May;12(5):301-11. doi: 10.1038/nrcardio.2015.28. Epub 2015 Mar 10.
2
Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study.英国一种新型心血管疾病风险评分QRISK的推导与验证：前瞻性开放队列研究
BMJ. 2007 Jul 21;335(7611):136. doi: 10.1136/bmj.39261.471806.55. Epub 2007 Jul 5.
3
Using thresholds based on risk of cardiovascular disease to target treatment for hypertension: modelling events averted and number treated.
利用基于心血管疾病风险的阈值来确定高血压的治疗目标：对避免的事件和治疗人数进行建模。
BMJ. 2000 Mar 11;320(7236):680-5. doi: 10.1136/bmj.320.7236.680.
4
Guidelines on preventing cardiovascular disease in clinical practice.临床实践中预防心血管疾病指南。
BMJ. 2000 Mar 11;320(7236):659-61. doi: 10.1136/bmj.320.7236.659.
5
Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association.英国关于临床实践中冠心病预防的联合建议。英国心脏病学会、英国高脂血症协会、英国高血压学会，获英国糖尿病协会认可。
Heart. 1998 Dec;80 Suppl 2(Suppl 2):S1-29.
6
A predictive model of the health benefits and cost effectiveness of celiprolol and atenolol in primary prevention of cardiovascular disease in hypertensive patients.塞利洛尔和阿替洛尔在高血压患者心血管疾病一级预防中的健康效益及成本效益预测模型
Pharmacoeconomics. 1997 Sep;12(3):384-408. doi: 10.2165/00019053-199712030-00010.
7
Number needed to treat. Absolute risk reduction may be easier for patients to understand.需治疗人数。绝对风险降低率可能对患者来说更容易理解。
BMJ. 1995 May 13;310(6989):1269. doi: 10.1136/bmj.310.6989.1269.